Precision cancer prevention represents a paradigm shift in our approach to reducing cancer risk and preventing cancer development. By leveraging advances in genomics, epidemiology, and behavioral science, researchers can identify individuals at elevated risk of developing cancer and implement tailored interventions to mitigate their risk.
Additionally, chemoprevention strategies, including the use of pharmacologic agents such as tamoxifen and aspirin, have shown promise in reducing cancer incidence in high-risk populations.
Consultation can be done by :